Page 1952 - Cote clinical veterinary advisor dogs and cats 4th
P. 1952
Thyroid Neoplasia 976.e1
ADDITIONAL SUGGESTED RELATED CLIENT EDUCATION
READINGS SHEETS
VetBooks.ir Broome MR, et al: Clinical features and treatment Consent to Perform Fine-Needle Aspiration Diseases and Disorders
outcomes of 41 dogs with sublingual ectopic thyroid
of Masses
neoplasia. J Vet Intern Med 28:1560-1568, 2014.
Campos M, et al: Clinical, pathologic, and immu-
nohistochemical prognostic factors in dogs with Consent to Perform Radiography
thyroid carcinoma. J Vet Intern Med 28:1805-1813,
2014.
Campos M, et al: Upregulation of the PI3K/Akt
pathway in the tumorigenesis of canine thyroid
carcinoma. J Vet Intern Med 28:1814-1823, 2014.
Carver JR, et al: A comparison of medullary thyroid
carcinoma and thyroid adenocarcinoma in dogs: a
retrospective study of 38 cases. Vet Surg 24:315-
319, 1995.
Castillo V, et al: Post-surgical treatment of thyroid
carcinoma in dogs with retinoic acid 9 cis improves
patient outcome. Open Vet J 6:6-14, 2016.
Leach TN, et al: Prospective trial of metronomic
chlorambucil chemotherapy in dogs with naturally
occurring cancer. Vet Comp Oncol 10:102-112,
2012.
London C, et al: Preliminary evidence for biologic
activity of toceranib phosphate (Palladia®) in solid
tumors. Vet Comp Oncol 10:194-205, 2012.
Looney A, et al: Dietary management of hyperthyroid-
ism in a dog. J Am Anim Hosp Assoc 53:111-118,
2017.
Pack L, et al: Definitive radiation therapy for
infiltrative thyroid carcinoma in dogs. Vet Radiol
Ultrasound 42:471-474, 2001.
Theon AP, et al: Prognostic factors and patterns
of treatment failure in dogs with unresectable
differentiated thyroid carcinomas treated with
megavoltage irradiation. J Am Vet Med Assoc
216:1775-1779, 2000.
Turrel JM, et al: Sodium iodide I 131 treatment of
dogs with nonresectable thyroid tumors: 39 cases
(1990-2003). J Am Vet Med Assoc 229:542-548,
2006.
Urie BK, et al: Evaluation of expression and function
of vascular endothelial growth factor receptor 2,
platelet derived growth factor receptors-alpha and
-beta, KIT, and RET in canine apocrine gland anal
sac adenocarcinoma and thyroid carcinoma. BMC
Vet Res 8:67, 2012.
131
Worth AJ, et al: Radioiodide ( I) therapy for the
treatment of canine thyroid carcinoma. Aust Vet
J 83:208-214, 2005.
www.ExpertConsult.com